• Obese Kids May Face Higher Odds for Eczema, Psoriasis

    Obese kids are more likely to develop immune-based skin problems like eczema or psoriasis, a new study says. Analysis of more than 2.1 million Korean children between 2009 and 2020 revealed that children who became overweight had...

    • Posted August 21, 2024
    • 13
  • COVID Vaccine Won’t Trigger MS Relapse: Study

    Multiple sclerosis makes people vulnerable to more severe cases of COVID-19, but a new study finds that getting the COVID vaccine won’t trigger a relapse of MS symptoms. “People with MS have an increased risk of severe...

    • Posted August 21, 2024
    • 17
  • ‘Mindful Breathing’ Might Ease Cancer-Related Pain, Anxiety

    A meditation technique called mindful breathing can help cancer patients manage their pain and anxiety, a new study finds. Cancer patients who engaged in 20 minutes of mindful breathing experienced a greater reduction in pain than those...

    • Posted August 21, 2024
    • 1
  • PE Class: It Can Boost a Child’s Body and Mind

    A quality physical education program involves more than just getting kids to move for a set amount of time during the school day, experts say. PE classes can teach lessons not found in any other classroom, Erika...

    • Posted August 21, 2024
    • 12
  • New ‘Platelet Score’ Could Gauge Your Odds for Stroke, Heart Attack

    An experimental genetic test can gauge a person’s risk of developing potentially deadly blood clots, researchers report. People who scored high on the test had more than double the rate of heart attack, stroke and major amputation...

    • Posted August 21, 2024
    • 3
  • Naloxone Might Help Revive People After Opioid-Linked Cardiac Arrest

    The overdose-reversing drug naloxone can help save the lives of people whose hearts have stopped due to an opioid OD, a new study shows. Naloxone rapidly reverses opioid ODs by blocking the ability of opioids to bind...

    • Posted August 20, 2024
    • 5
  • Mounjaro, Zepbound Cut Odds for Diabetes by 94% in At-Risk People, Study Finds

    Tirzepatide, the blockbuster GLP-1 medicine known as Mounjaro for diabetes and Zepbound for weight loss, cut the odds that an obese, prediabetic person will develop diabetes by 94%, a new trial shows. The three-year-long trial, funded by...

    • Posted August 20, 2024
    • 11
  • U.S. Births Continue to Fall, Dropping by 17% Since 2007

    Final government data finds the number of U.S. births falling by 2% last year compared to 2022, continuing a decades-long decline. Overall, annual U.S. birth numbers have fallen by 17% since peaking in 2007, according to the...

    • Posted August 20, 2024
    • 16
  • FDA Could OK Fall COVID Shots as Early as This Week

    Updated shots you could use this fall to shield against COVID-19 infection may receive approval this week. Two sources familiar with the issue told CNN that updated mRNA vaccines from Moderna and Pfizer that target a variant...

    • Posted August 20, 2024
    • 12
  • Is Dialysis Always Warranted for End-Stage Kidney Failure?

    Some seniors with end-stage kidney failure who are too sick for a transplant should probably skip dialysis because the health trade-offs aren’t worth it, a new study says. Seniors who started dialysis immediately after diagnosis with kidney...

    • Posted August 20, 2024
    • 15